During the past decade, Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii" are "Dermatitis, Atopic" (3 trials), "Dermatitis" (2 trials), "Eczema" (2 trials), "Genetic Diseases, Inborn" (2 trials) and "Hypersensitivity" (2 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii" in a lesser frequency.

Most popular intervention types in "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".